Belgium may remove step between paying doctors and reimbursement

8 October 2021 - Doctors and dentists could soon choose to only charge patients for co-payments – the non-refundable part ...

Read more →

Pear Therapeutics announces additional coverage decisions and formulary adoption of its prescription digital therapeutics

23 September 2021 - More than 30 organizations now provide access to Pear’s prescription digital therapeutics by either listing on formulary, ...

Read more →

Talks to recover reimbursement for dementia treatment aid almost complete

18 August 2021 - The negotiations on retrieving the reimbursement of pharmaceutical pricing for choline alfoscerate drugs to help treat ...

Read more →

Oncopeptides' Pepaxto receives a permanent J code, clarifying reimbursement processes in hospital outpatient and physician office settings of care

16 August 2021 - Oncopeptides today announced that the Centers for Medicare and Medicaid Services has established a specific billing Level ...

Read more →

Delcath Systems announces revised NICE guidance for Chemosat in the United Kingdom

21 April 2021 - Recommends special arrangement designation which increases reimbursement options. ...

Read more →

HHS regulations with enduring impact on pricing and reimbursement of medical services and technologies

17 January 2021 - The Trump Administration’s grandiose healthcare plans didn’t come to fruition, like the promised repeal and replace of ...

Read more →

COVID-19 vaccine codes: updated effective date for Pfizer-BioNTech

14 December 2020 - During the COVID-19 public health emergency, Medicare will cover and pay for the administration of the vaccine ...

Read more →

Though promising, gene therapies face durability and reimbursement headwinds

11 December 2020 - The promise of gene therapy is to cure diseases associated with faulty or missing genes. There’s enormous ...

Read more →

Radiopharmaceutical Lutathera now reimbursed in Quebec for cancer patients with advanced gastro-enteropancreatic neuroendocrine tumours

1 October 2020 - Lutathera is the first and only therapeutic radiopharmaceutical indicated in the treatment of GEP-NETs in Canada. ...

Read more →

Pear Therapeutics and PreferredOne announce broad based patient access and reimbursement for reSET & reSET-O for people with substance use disorder and opioid use disorder

21 September 2020 - PreferredOne teams with Pear to provide its members with covered access to two prescription digital therapeutics for ...

Read more →

CMS grants additional reimbursement for the Eluvia drug eluting vascular stent system

3 September 2020 - Boston Scientific announced that the U.S. Centers for Medicare and Medicaid Services granted a new technology add-on ...

Read more →

The reimbursement for medicines is expected to decrease by SEK 185 million in 2020

26 June 2020 - Pharmaceutical companies will pay SEK 2.9 billion in reimbursement for medicines covered by side agreements between ...

Read more →

Camurus' Buvidal reimbursed in Sweden for the treatment of opioid dependence

14 May 2020 - Buvidal (buprenorphine) prolonged release injection receives reimbursement in Sweden from the 15 May 2020 after approval by ...

Read more →

Digital therapeutics leaders focus on reimbursement

23 February 2020 - This past week the Digital Therapeutics West conference was held in Silicon Valley. CEOs, venture capitalists, and ...

Read more →

FDA's Gottlieb 'extremely worried' on CAR-T reimbursement

24 October 2018 - FDA Commissioner Scott Gottlieb stressed the need for reform on the reimbursement side of medicine, calling it ...

Read more →